- Home
- CIA vs LXRX Comparison
CIA vs LXRX Comparison
Compare CIA & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIA
- LXRX
- Stock Information
- Founded
- CIA 1969
- LXRX 1995
- Country
- CIA United States
- LXRX United States
- Employees
- CIA N/A
- LXRX N/A
- Industry
- CIA Life Insurance
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- CIA Finance
- LXRX Health Care
- Exchange
- CIA Nasdaq
- LXRX Nasdaq
- Market Cap
- CIA 212.6M
- LXRX 228.8M
- IPO Year
- CIA N/A
- LXRX 2000
- Fundamental
- Price
- CIA $3.54
- LXRX $0.63
- Analyst Decision
- CIA
- LXRX Buy
- Analyst Count
- CIA 0
- LXRX 4
- Target Price
- CIA N/A
- LXRX $3.67
- AVG Volume (30 Days)
- CIA 103.9K
- LXRX 3.8M
- Earning Date
- CIA 06-17-2025
- LXRX 05-13-2025
- Dividend Yield
- CIA N/A
- LXRX N/A
- EPS Growth
- CIA N/A
- LXRX N/A
- EPS
- CIA 0.17
- LXRX N/A
- Revenue
- CIA $242,941,000.00
- LXRX $31,213,000.00
- Revenue This Year
- CIA $3.89
- LXRX N/A
- Revenue Next Year
- CIA $6.08
- LXRX $46.60
- P/E Ratio
- CIA $21.01
- LXRX N/A
- Revenue Growth
- CIA 0.19
- LXRX 1251.21
- 52 Week Low
- CIA $2.33
- LXRX $0.28
- 52 Week High
- CIA $5.95
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- CIA 37.41
- LXRX 51.09
- Support Level
- CIA $3.53
- LXRX $0.52
- Resistance Level
- CIA $3.91
- LXRX $0.72
- Average True Range (ATR)
- CIA 0.22
- LXRX 0.05
- MACD
- CIA -0.02
- LXRX -0.00
- Stochastic Oscillator
- CIA 4.88
- LXRX 58.10
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.